The age

at disease diagnosis was lower in carriers of the ESR1 rs9340799 A allele compared with GG homozygotes as well as in patients with ESR1 rs2234693 TT and CT genotypes compared with CC homozygotes. There was no significant association of the genotypes with rheumatoid factor (RF), erosive disease, extra-articular manifestations, or anti-cyclic citrullinated peptide (anti-CCP) antibodies.\n\nConclusions: The results of the study suggest that polymorphisms in the ESR1 gene may be associated with the age of onset of RA.”
“Objective: To determine whether ovaries can be preserved in selected young women with peritoneal pseudomyxoma (PMP).\n\nBackground data: The traditional https://www.selleckchem.com/ATM.html rule is to systematically perform a bilateral oophorectomy.\n\nPatients and methods: A new policy was developed to preserve the ovaries when they are macroscopically normal in young women with PMP, strongly desiring a future pregnancy.\n\nResults: Thirty-three women younger than 41 years were

selected after undergoing complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for PMP. A normal ovary was preserved in 6 of them, but in see more 6 of the 14 women who strongly desired a future pregnancy. Subsequently, ovarian preservation was only performed in cases of grade-1 PMP. Ovarian invasion was correlated with the grade (p < 0.05) and with the extent of peritoneal disease (p < 0.01). After

a median follow-up of 54 months, none of the 6 women with preserved ovaries has developed an ovarian or a peritoneal recurrence. One woman became pregnant Metabolism inhibitor and egg harvesting and cryopreservation were performed for 4 women with a partially normal ovary.\n\nConclusion: This new policy allowed ovarian preservation in 43% of the young women desiring a future pregnancy and has already resulted in one birth. It exclusively concerned low-grade PMP. Recurrence in the preserved ovary was 0% with our selection criteria. (C) 2013 Elsevier Ltd. All rights reserved.”
“Background: The aim of the study was to identify the relationship between ‘Health Belief Model Scale for Cervical Cancer and the Pap Smear Test’ subscale scores and demographic/gyneco-obstetric characteristics. Materials and Methods: This cross-sectional study was conducted with 256 women. Data were obtained using the ‘Demographic and Gyneco-Obstetric Identification Form’ and the ‘Health Belief Model Scale for Cervical Cancer and the Pap Smear Test. Results: The percentage of women who had heard about the Pap test was 77.7 whereas only 32.4% had actually undergone the test. Some 45.7% of the women stated that they did not know the reason for having a Pap test. Women who had obtained a Pap smear test had statistically significantly fewer perceived barriers than those who had never had (p<0.05).